JEROME B ZELDIS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JEROME B ZELDIS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JEROME B ZELDIS. JEROME B ZELDIS is Director in SOLIGENIX, INC. ($DOR) and Director in Alliqua BioMedical, Inc. ($ALQA) and Director in PTC THERAPEUTICS, INC. ($PTCT) and See Remarks in Sorrento Therapeutics, Inc. ($SRNE) and in MetaStat, Inc. ($MTST) and Director in BioSig Technologies, Inc. ($BSGM) and Executive VP of Research & Dev in NexImmune, Inc. ($NEXI).
Latest Insider Trading Transactions of JEROME B ZELDIS
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALQA, BSGM, MTST, NEXI, PTCT, SNGX, SRNE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 16 2021 | NEXI | NexImmune, Inc. | ZELDIS JEROME B | Executive VP of Res ... | Option Exercise | A | 17.00 | 351,016 | 5,967,272 | 351,016 | |
Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | ZELDIS JEROME B | Director | Option Exercise | A | 66.49 | 10,000 | 664,900 | 10,000 | |
Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | ZELDIS JEROME B | Director | Grant | A | 0.00 | 1,650 | 0 | 3,300 | 1.7 K to 3.3 K (+100.00 %) |
Sep 18 2020 | SNGX | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Option Exercise | A | 1.97 | 15,228 | 29,999 | 15,228 | |
Jul 15 2020 | BSGM | BioSig Technologie ... | ZELDIS JEROME B | Director | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Jul 15 2020 | BSGM | BioSig Technologie ... | ZELDIS JEROME B | Director | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
May 28 2020 | BSGM | BioSig Technologie ... | ZELDIS JEROME B | Director | Buy | P | 10.49 | 1,000 | 10,489 | 107,944 | 106.9 K to 107.9 K (+0.94 %) |
Apr 16 2020 | BSGM | BioSig Technologie ... | ZELDIS JEROME B | Director | Option Exercise | A | 4.66 | 50,000 | 233,000 | 50,000 | |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | ZELDIS JEROME B | Director | Option Exercise | A | 51.16 | 10,000 | 511,600 | 10,000 | |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | ZELDIS JEROME B | Director | Grant | A | 0.00 | 1,650 | 0 | 1,650 | 0 to 1.7 K |
Nov 19 2019 | SNGX | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Buy | P | 0.93 | 2,000 | 1,850 | 22,917 | 20.9 K to 22.9 K (+9.56 %) |
Oct 31 2019 | BSGM | BioSig Technologie ... | ZELDIS JEROME B | Director | Option Exercise | A | 7.15 | 29,000 | 207,350 | 29,000 | |
Sep 23 2019 | SNGX | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Buy | P | 0.94 | 4,000 | 3,740 | 20,917 | 16.9 K to 20.9 K (+23.64 %) |
Sep 10 2019 | SNGX | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Option Exercise | A | 0.97 | 30,928 | 30,000 | 30,928 | |
Sep 10 2019 | SNGX | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Option Exercise | A | 0.97 | 30,928 | 30,000 | 30,928 | |
May 22 2019 | BSGM | BioSig Technologie ... | ZELDIS JEROME B | Director | Option Exercise | M | 6.85 | 1,097 | 7,514 | 0 | |
May 22 2019 | BSGM | BioSig Technologie ... | ZELDIS JEROME B | Director | Option Exercise | M | 3.40 | 20,000 | 68,000 | 0 | |
May 22 2019 | BSGM | BioSig Technologie ... | ZELDIS JEROME B | Director | Option Exercise | C | 3.75 | 50 | 188 | 0 | |
May 22 2019 | BSGM | BioSig Technologie ... | ZELDIS JEROME B | Director | Buy | M | 6.85 | 1,097 | 7,514 | 106,944 | 105.8 K to 106.9 K (+1.04 %) |
May 22 2019 | BSGM | BioSig Technologie ... | ZELDIS JEROME B | Director | Buy | M | 3.40 | 20,000 | 68,000 | 105,847 | 85.8 K to 105.8 K (+23.30 %) |
May 22 2019 | BSGM | BioSig Technologie ... | ZELDIS JEROME B | Director | Grant | A | 7.44 | 3,804 | 28,302 | 85,847 | 82 K to 85.8 K (+4.64 %) |
May 22 2019 | BSGM | BioSig Technologie ... | ZELDIS JEROME B | Director | Buy | C | 3.75 | 13,334 | 50,003 | 82,043 | 68.7 K to 82 K (+19.41 %) |
Apr 22 2019 | SNGX | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Buy | P | 0.73 | 10,000 | 7,274 | 16,917 | 6.9 K to 16.9 K (+144.57 %) |
Apr 22 2019 | SNGX | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Buy | P | 0.73 | 10,000 | 7,274 | 16,917 | 6.9 K to 16.9 K (+144.57 %) |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | ZELDIS JEROME B | Director | Option Exercise | A | 33.02 | 14,000 | 462,280 | 14,000 | |
Nov 27 2018 | SRNE | Sorrento Therapeut ... | ZELDIS JEROME B | See Remarks | Option Exercise | A | 3.57 | 100,000 | 357,000 | 100,000 | |
Sep 28 2018 | SNGX | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Option Exercise | A | 1.67 | 17,964 | 30,000 | 17,964 | |
Jan 05 2018 | PTCT | PTC THERAPEUTICS, ... | ZELDIS JEROME B | Director | Option Exercise | A | 18.01 | 14,000 | 252,140 | 14,000 | |
Nov 21 2017 | MTST | MetaStat, Inc. | ZELDIS JEROME B | Option Exercise | M | 0.00 | 50,000 | 0 | 50,000 | ||
Sep 15 2017 | SRNE | Sorrento Therapeut ... | ZELDIS JEROME B | See Remarks | Option Exercise | A | 1.80 | 150,000 | 270,000 | 150,000 | |
Jul 03 2017 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Option Exercise | A | 0.37 | 90,000 | 33,300 | 90,000 | |
Jun 26 2017 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Buy | J | 0.00 | 100,000 | 0 | 786,750 | 686.8 K to 786.8 K (+14.56 %) |
Jun 12 2017 | DOR | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Option Exercise | A | 2.29 | 13,100 | 29,999 | 13,100 | |
Apr 06 2017 | MTST | MetaStat, Inc. | ZELDIS JEROME B | Buy | P | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K | |
Mar 01 2017 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Buy | P | 0.50 | 400,000 | 200,000 | 686,750 | 286.8 K to 686.8 K (+139.49 %) |
Feb 09 2017 | BSGM | BioSig Technologie ... | ZELDIS JEROME B | Director | Option Exercise | A | 1.36 | 50,000 | 68,000 | 50,000 | |
Feb 03 2017 | SRNE | Sorrento Therapeut ... | ZELDIS JEROME B | See Remarks | Buy | P | 5.15 | 10,000 | 51,500 | 10,000 | 0 to 10 K |
Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | ZELDIS JEROME B | Director | Option Exercise | A | 11.23 | 12,000 | 134,760 | 12,000 | |
Nov 15 2016 | SRNE | Sorrento Therapeut ... | ZELDIS JEROME B | See Remarks | Option Exercise | A | 6.52 | 200,000 | 1,304,000 | 200,000 | |
May 13 2016 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Option Exercise | A | 0.86 | 45,000 | 38,700 | 45,000 | |
Jan 06 2016 | PTCT | PTC THERAPEUTICS, ... | ZELDIS JEROME B | Director | Option Exercise | A | 30.86 | 12,000 | 370,320 | 12,000 | |
Dec 23 2015 | DOR | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Buy | P | 1.27 | 2,500 | 3,175 | 69,166 | 66.7 K to 69.2 K (+3.75 %) |
Nov 09 2015 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Buy | P | 2.91 | 14,000 | 40,740 | 286,750 | 272.8 K to 286.8 K (+5.13 %) |
Jun 19 2015 | DOR | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Option Exercise | A | 1.51 | 19,868 | 30,001 | 19,868 | |
May 08 2015 | ALQA | Alliqua BioMedical ... | ZELDIS JEROME B | Director | Option Exercise | A | 4.73 | 15,000 | 70,950 | 15,000 | |
Apr 09 2015 | DOR | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Option Exercise | M | 0.61 | 17,857 | 10,893 | 0 | |
Apr 09 2015 | DOR | SOLIGENIX, INC. | ZELDIS JEROME B | Director | Buy | M | 0.61 | 17,857 | 10,893 | 66,666 | 48.8 K to 66.7 K (+36.59 %) |
Page: 1